Allakos Inc. (ALLK) earnings
ALLK earnings moved a median of -0.03% by the close. Quarterly and annual ALLK reports and results, each read against the price at its own news timestamp. Back to the ALLK overview →
13 measured ALLK earnings events.
Where these ALLK earnings landedvs 13 measured ALLK earnings reactions
| Middle 50% of ALLK earnings reactions | -0.83% to +2.04% |
|---|---|
| Median reaction (to close) | -0.03% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 ALLK earnings events with a measured close landed between -0.83% and +2.04%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Allakos Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.03% | |
| Form 10-K/A Allakos Inc. For: Dec 31 | SEC filing · Form 10-K | +0.93% | +1.22% | |
| Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results | Press release | +4.74% | +2.04% | |
| Form 10-K Allakos Inc. For: Dec 31 | SEC filing · Form 10-K | +4.74% | +2.04% | |
| Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results | Press release | +0.00% | -2.17% | |
| Form 10-Q Allakos Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.17% | |
| Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results | Press release | +0.00% | -0.03% | |
| Form 10-Q Allakos Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.03% | |
| Allakos Provides Business Update and Reports First Quarter 2024 Financial Results | Press release | +0.00% | -0.83% | |
| Form 10-Q Allakos Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.83% | |
| Form 10-K Allakos Inc. For: Dec 31 | SEC filing · Form 10-K | -1.55% | +1.55% | |
| Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results | Press release | -4.71% | +7.65% | |
| Form 10-Q Allakos Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.71% | +7.65% |
Keep exploring
More ALLK: analyst actions → · SEC filings → · ALLK overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | 249 | -0.34% | 42% |
| Soligenix, Inc. (SNGX) | 249 | -0.70% | 36% |
| Avadel Pharmaceuticals plc - Ordinary Share (AVDL) | 248 | -0.17% | 41% |
| Cytosorbents Corporation (CTSO) | 248 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.